Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

According to Makary and Prasad, the US’s adoption of a “one-size-fits-all” guidance for COVID-19 vaccination departs from ...

WEDNESDAY May 21, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has decided that only seniors and ...

The U.S. Food and Drug Administration (FDA) is changing the game on COVID-19 vaccines. Instead of approving yearly boosters ...

Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

FDA changes COVID-19 vaccine approval policy, major trials now required for widespread use. Higher risk individuals still ...

Blood and urine tests might be able to reveal how much of your diet is made up of industrially produced foods, a new study ...